Evaluation of toxicity and adjuvant effects of peptidoglycan microspheres orally administered to mice

References

• Aktaş Y, Andrieux K, Alonso MJ, Calvo P, Gürsoy RN, Couvreur P, Capan Y. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. Int J Pharm, 2005;298:378–83
   PubMed Web of Science ®Google Scholar
• Borges O, Tavares J, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles. Eur J Pharm Sci, 2007;32(4–5):278–90
   PubMed Web of Science ®Google Scholar
• Candela T, Dumetz F, Tosi-Couture E, Mock M, Goossens PL, Fouet A. Cell-wall preparation containing poly-γ-d-glutamate covalently linked to peptidoglycan, a straightforward extractable molecule, protects mice against experimental anthrax infection. Vaccine, 2012;31:171–5
   PubMed Web of Science ®Google Scholar
• Di Martino A, Sittinger M, Risbud MV. Chitosan: A versatile biopolymer for orthopaedic tissue-engineering. Biomaterials, 2005;26:5983–90
   PubMed Web of Science ®Google Scholar
• Gavini E, Hegge AB, Rassu G, Sanna V, Testa C, Pirisino G, Karlsen J, Giunchedi P. Nasal administration of Carbamazepine using chitosan microspheres: In vitro/in vivo studies. Int J Pharm, 2006;307:9–15
   PubMed Web of Science ®Google Scholar
• Ge YB, Chen DW, Xie LP, Zhang RQ. Optimized preparation of daidzein-loaded chitosan microspheres and in vivo evaluation after intramuscular injection in rats. Int J Pharm, 2007;338:142–51
   PubMed Web of Science ®Google Scholar
• Habjanec L, Halassy B, Tomasic J. Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse. Int Immunopharmacol, 2010;10(7):751–9
   PubMedGoogle Scholar
• Halassy B, Krstanović M, Frkanec R, Tomasić J. Adjuvant activity of peptidoglycan monomer and its metabolic products. Vaccine, 2003;21:971–6
   PubMed Web of Science ®Google Scholar
• Halassy B, Mateljak S, Bouche FB, Pütz MM, Muller CP, Frkanec R, Habjanec L, Tomasić J. Immunogenicity of peptides of measles virus origin and influence of adjuvants. Vaccine, 2006;24:185–94
   PubMed Web of Science ®Google Scholar
• Halassy B, Vdović V, Habjanec L, Balija ML, Gebauer B, Sabioncello A, Santek T, Tomasić J. Effectiveness of novel PGM-containing incomplete Seppic adjuvants in rabbits. Vaccine, 2007;25:3475–81
   PubMedGoogle Scholar
• Halassy Spoljar B, Cimbora T, Hanzl-Dujmović I, Dojnović B, Sabioncello A, Krstanović M, Tomasić J. Influence of adjuvant-active peptidoglycan monomer on specific T cell responses in mice. Vaccine, 2002;20:3543–50
   PubMed Web of Science ®Google Scholar
• Han HD, Song CK, Park YS, Noh KH, Kim JH, Hwang T, Kim TW, Shin BC. A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. Int J Pharm, 2008;350:27–34
   PubMed Web of Science ®Google Scholar
• Hedl M, Li J, Cho JH, Abraham C. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci USA, 2007;104:19440–5
   PubMed Web of Science ®Google Scholar
• Hewitt RE, Pele LC, Tremelling M, Metz A, Parkes M, Powell JJ. Immuno-inhibitory PD-L1 can be induced by a Peptidogly-can/NOD2 mediated pathway in primary monocytic cells and is deficient in Crohn's patients with homozygous NOD2 mutations. Clin Immunol, 2012;143:162–9
   PubMedGoogle Scholar
• Jiang DS, Long SY, Huang J, Xiao HY, Zhou JY. Immobilization of laccase on magnetic chitosan microspheres and study on its enzymic properties. Wei Sheng Wu Xue Bao, 2005;45:630–3
   PubMedGoogle Scholar
• Kang GD, Song SC. Effect of chitosan on the release of protein from thermosensitive poly (organophosphazene) hydrogels. Int J Pharm, 2008;349(12):188–95
   PubMedGoogle Scholar
• Kang ML, Kang SG, Jiang HL, Shin SW, Lee DY, Ahn JM, Rayamahji N, Park IK, Shin SJ, Cho CS, Yoo HS. In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT. Eur J Pharm Biopharm, 2006;63:215–20
   PubMed Web of Science ®Google Scholar
• Kofuji K, Murata Y, Kawashima S. Sustained insulin release with biodegradation of chitosan gel beads prepared by copper ions. Int J Pharm, 2005;303:95–103
   PubMed Web of Science ®Google Scholar
• Ljevaković D, Tomasić J, Sporec V, Spoljar BH, Hanzl-Dujmovic I. Synthesis of novel adamantylacetyl derivative of peptidoglycan monomer—biological evaluation of immunomodulatory peptidoglycan monomer and respective derivatives with lipophilic substituents on amino group. Bioorg Med Chem, 2000;8:2441–9
   PubMed Web of Science ®Google Scholar
• Lubben IM, Verhoef JC, Borchard G. Chitosan for mucosal vaccination. Adv Drug Deliv Rev, 2001;52:139–44
   PubMed Web of Science ®Google Scholar
• Majeti NV, Kumar R. A review of chitin and chitosan applications. React Func Polym, 2000;46:1–27
   Web of Science ®Google Scholar
• Moreno M, Mol BM, von Mensdorff-Pouilly S, Verheijen RH, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJ. Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC). Cancer Lett, 2008;272(1):70–6
   PubMedGoogle Scholar
• Park KM, Bae JW, Joung YK, Shin JK, Park KD. Nanoaggregate of thermosensitive chitosan-Pluronic for sustained release of hydrophobic drug. Colloids Surf B, 2008;63:1–6
   PubMed Web of Science ®Google Scholar
• Rinaudo M. Chitin and chitosan: Properties and applications. Prog Polym Sci, 2006;31:603–32
   Web of Science ®Google Scholar
• Sáenz L, Neira-Carrillo A, Paredes R, Cortés M, Bucarey S, Arias JL. Chitosan formulations improve the immunogenicity of a GnRH-I peptide-based vaccine. Int J Pharm, 2009;369:64–71
   Google Scholar
• Saha S, Jing X, Park SY, Wang S, Li X, Gupta D, Dziarski R. Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-γ. Cell Host Microbe, 2010;8:147–62
   PubMed Web of Science ®Google Scholar
• Soo LP, Cho J, Grant J, Ho E, Piquette-Miller M, Allen C. Drug release mechanism of paclitaxel from a chitosan–lipid implant system: Effect of swelling, degradation and morphology. Eur J Pharm Biopharm, 2008;69:149–57
   PubMed Web of Science ®Google Scholar
• Sun QS, Han DQ, Lei H, Zhao K, Zhu L, Li XD, Fu HG. Preparation and characterization of chitosan microsphere loading bovine serum albumin. J Wuhan Univ Technol, 2012;27:459–64
   Google Scholar
• Tomasić J, Hanzl-Dujmović I, Spoljar B, Vranesić B, Santak M, Jovicić A. Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse. Vaccine, 2000;18:1236–43
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen J, Li H, Wang Y, Xie Z, Wu M, Zhang H, Zhao Z, Chen Q, Fu M. Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine. Comp Immunol Microbiol Infect Dis, 2007a;30(1):19–32
   PubMedGoogle Scholar
• Yang Z, Fuss IJ, Watanabe T, Asano N, Davey MP, Rosenbaum JT, Strober W, Kitani A. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. Gastroenterology, 2007b;133:1510–21
   PubMed Web of Science ®Google Scholar
• Yen MT, Yang JH, Mau JL. Physicochemical characterization of chitin and chitosan from crab shells. Carbohydr Polym, 2009;75:15–21
   Web of Science ®Google Scholar
• Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine, 2007;25:2085–94
   PubMed Web of Science ®Google Scholar
• Zhang C, Cheng Y, Qu GW. Preparation and characterization of galactosylated chitosan coated BSA microspheres containing 5-fluorouracil. Carbohydr Polym, 2008;72:390–7
   Web of Science ®Google Scholar
• Zhang H, Cheng C, Zheng M, Chen JL, Meng MJ, Zhao ZZ, Chen Q, Xie Z, Li JL, Yang Y, et al. Enhancement of immunity to an Escherichia coli vaccine in mice orally inoculated with a fusion gene encoding porcine interleukin 4 and 6. Vaccine, 2007;25:7094–101
   PubMed Web of Science ®Google Scholar
• Zhao K, Shi X, Zhao Y, Wei H, Sun Q, Huang T, Zhang X, Wang Y. Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Vaccine, 2011;29(47):8549–56
   PubMedGoogle Scholar
• Zhu L, Han DQ, Sun QS, Wu T, Li HZ. Microcapsulation of cytoderm peptidoglycan derived from Lactobacillus plantarum. Food Sci, 2011;32(17):27–31
   Google Scholar